ClinicalTrials.gg
CompletedNCT07637838Updated Oct 29, 2026Results posted

Characterizing the Effects of Platelet-Rich Fibrin (PRF) as a Palatal Wound Dressing on Quality of Life and Sleep Following Mucogingival Surgery. Study Was Conducted at the Air Force Post Graduate Dental School. All HIPPA Consents and Research Informed Consents Are Located at JBSA-Lackland.

An interventional study of Platelet rich fibrin and Control Group: collagen matrices or oxidized cellulose membrane in Palatal Donor Site Wound Healing, Platelet Rich Fibrin and Sleep Quality, sponsored by 59th Medical Wing. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by 59th Medical Wing · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled May 2024, registered May 2026).
Updated Oct 29, 2026Results postedPrimary outcomes revised+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States — 149 open to participants now, 186 under way, 5 of them phase 3. Sleep Initiation and Maintenance Disorders · United States.

Enrollment
353rd of 858
78 · median 60
Started
2024
with 60 others
No phase
580 of 907
110 open now
Registered
871st of 907
by date

Among the 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States, this one is the 353rd largest by enrollment of the 858 interventional ones that give a count, is one of 61 that started in 2024, is one of 580 with no phase, and was the 871st registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

149 of the 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States are open now. Recruiting first, the newest first:

144 more — sign in →

All 149 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial (2-arm) is to determine if the application of platelet rich fibrin (PRF) to palatal donor sites influence patients quality of life, sleep efficiency, and healing following mucogingival surgery. All patients were enrolled in the Air Force Post Graduate Dental School periodontics program and each patient required mucogingival surgery. The main question[s] it aims to answer [is/are]:

  • Does the application of PRF to palatal donor sites influence patient's quality of life following mucogingival surgery. [outcome measure 1]
  • Does the application of PRF to palatal donor sites influence patient's sleep quality following mucogingival surgery. [outcome measure 2]
  • Does the application of PRF to palatal donor sites influence palatal healing following mucogingival surgery. [outcome measure 3] Researchers will compare the application of PRF (test) as a palatal dressing to a commercially available product (control; oxidized cellulose membrane or collagen dressing) to determine the difference of effects.

Participants will be randomly assigned to either receiving PRF or a commercially available product on the day of surgery. A survey response will be conducted at five time points (pre-operative, 24-hours, 72 hours, 1 week, 2 week) to obtain a quality of life metric. Sleep data was collected via a wearable device one week pre-surgical intervention and two weeks postoperatively. Finally, a clinical healing index was performed at 1 and 2 weeks post-operatively to obtain a healing score.

03

Conditions studied

  • Palatal Donor Site Wound Healing
  • Platelet Rich Fibrin
  • Sleep Quality
  • Pain
  • Analgesic Consumption

Keywords

  • quality of life
  • platelet-rich fibrin
  • pain
  • palate
  • wound healing
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age > 18 or \< 99
  • required a mucogingival surgery
  • had not taken an antibiotic for one month
  • planned for a non-emergent periodontal procedure

Exclusion criteria

Exclusion Criteria:

  • pregnant or within 6 months post-partum
  • female subjects who are nursing
  • subjects who are decisionally challenged
  • patients who have undergone antibiotic therapy in the past month
  • or higher status
  • patients who have undergone chronic therapy with medications that could affect periodontal status or healing
  • incompatible mobile phone devices.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
78 participants (actual)

Study arms

  • Experimental
    Test Group: Horizontally Centrifuged PRF membranes used as palatal dressing

    The test group had approximately 40 ml of whole venous blood collected from their antecubital fossa (R/L) prior to surgical start for the fabrication of PRF. Tubes were placed immediately into a US Food and Drug Administration (FDA)-approved horizontal centrifuge (Horizon 6 Drucker Diagnostics; Port Matilda, PA), and spun at 2300 rpm (700 g) for 16 min. After the centrifugation was complete, the PRF matrices were compressed into membranes. At the completion of surgery, PRF membranes (1-3) were placed at the harvest site. A palatal stent was used to secure the wound dressings via compression only, and no sutures were utilized for fixation at the harvest sites.

    Procedure: Platelet rich fibrin

  • Active comparator
    Control Group: Collagen wound dressing or oxidized cellulose membrane

    The control group had a commercially available wound dressing placed at the harvest site. A palatal stent was used to secure the wound dressing via compression only, and no sutures were utilized for fixation at the harvest sites.

    Other: Control Group: collagen matrices or oxidized cellulose membrane

Interventions

  • ProcedurePlatelet rich fibrin

    The test group had approximately 40 ml of whole venous blood collected from their antecubital fossa (R/L) prior to surgical start for the fabrication of PRF. Tubes were placed immediately into a US Food and Drug Administration (FDA)-approved horizontal centrifuge (Horizon 6 Drucker Diagnostics; Port Matilda, PA), and spun at 2300 rpm (700 g) for 16 min. After the centrifugation was complete, the PRF matrices were compressed into membranes. At the completion of surgery, PRF membranes (1-3) were used as a wound dressing at the harvest site. A palatal stent was used to secure the PRF via compression only, and no sutures were utilized for fixation at the harvest sites. Patients were instructed not to remove the palatal stent for 48 hours.

  • OtherControl Group: collagen matrices or oxidized cellulose membrane

    On the day of surgery, subjects randomized into the control group had a commercially available product of the surgeons choice (collagen matrices or oxidized cellulose membrane) placed at the palatal donor site. The matrix was compressed with a palatal stent and subjects were instructed to not remove the stent for 48 hours.

06

What researchers measure

Primary outcomes

  1. Quality of Life: Oral Health Impact Profile -14 (OHIP-14). Summative Scores Were Utilized as a Quality of Life Metric at Five Different Time Points. These Scores Were Compared Between the Test and Control Group.

    OHIP-14 Questionnaire: includes 7 patient domains (2 questions for each domain). 1. Functional Limitation 2. Physical pain 3. Psychological discomfort 4. Physical disability 5. Psychological disability 6. Social disability 7. Handicap Patients are asked to answer questions on the 5-point Likert scale below. The additive total of the 14 questions is the total OHIP-14 score. Lower scores correlate to higher Quality of Life (QoL). A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted. Likert Scale answer choices: Very Often(4), Fairly Often(3), Occasionally(2), Hardly Ever (1), Never(0). Range: 0-54. High QoL (OHIP Score: \< 19), Moderate QoL (OHIP-14 Score: 19-37), Low QoL (OHIP-14 Score 38-56). OHIP-14 was completed pre-surgically, 24 hours, 72 hours, 1 week, and 2 weeks.

    Time frame: Pre-surgical survey to 2 weeks following surgical intervention.

  2. Sleep Quality: Sleep Quality Index (SQI) Was Obtained From Wearable Device Which Serves as a Summary Index of the Cardiopulmonary Coupling Biomarkers of Sleep Quality, Sleep Stability, Fragmentation, and Periodicity.

    A sleep monitoring device was issued to patients following informed consent (SleepImage® Ring 2019, SleepImage, Denver, CO). The sleep monitoring app will be downloaded on subjects' phones and each subject will be briefed on the function of the application. Subjects will be instructed to wear the device nightly throughout the study. SQI (sleep quality index) scale is 1-100. Higher numbers are consistent with a higher quality sleep. Average baseline (pre-surgery) SQI was recorded. 24 hour, 72 hour, average sleep quality in week 1, and average sleep quality in week 2. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted for sleep analysis.

    Time frame: 1 week pre-surgery to 2-weeks following surgical intervention.

Secondary outcomes

  1. Pain: a Numeric Pain Scale (0-10) Was Used to Document Site Specific Palatal Harvest Pain.

    The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion asking a question regarding pain at the palatal harvest site. Survey question: What is your pain at the palatal harvest site on a scale of 0-10? (NRS-11). 0 (minimum) indicates no pain. 10 (maximum) is extreme pain. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.

    Time frame: From pre-surgery survey, final survey was 2 weeks post surgical intervention.

  2. Analgesic Consumption: a (Yes/No) Survey Question Was Asked Regarding Analgesic Consumption. If the Patient Answered "Yes" to Using Medications to Relieve Pain, They Were Added to the Number of Participants Who Used Medication at That Time Point.

    The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion. Survey question: Did you take any mediation today to relieve pain or swelling? (yes/no). This was measured by number of participants who took medication to relieve pain and swelling. If a participant answered "Yes" to the survey question at the specific time point, they were counted as having taking medications to relieve pain or swelling. If they answered "No" they were note included. Amount of analgesic use was not documented. Simply a dichotomous "Yes" or "No". A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.

    Time frame: From pre-surgery survey to two weeks post surgical intervention.

  3. Physiologic Healing at Palatal Donor Site: 5-point Healing Scale Landry et al Scale

    At the follow-up appointments the surgeons were asked to document the presence of suppuration or bleeding at the palatal wound site. A standardized photograph was then taken with the following parameters (F-stop: 29, ISO: 200, Shutter Speed: 125). Two calibrated, blinded examiners then assessed the palatal wound based on the Landry et al palatal healing index. Each examiner provided a score (1-5). Lower scores = poorer healing. Higher scores = advanced healing. If the scores were not in concordance, a third calibrated blind examiner assessed the palatal wound based on the Landry et al palatal healing index. This served as the "tie-breaker" score. For example, if examiner #1 scored a (1), and examiner #2 scored a (2), the palate was examined by the third examiner. If examiner #3 scored a (2) then the patient received a score of (2). If the third examiner scored a different number then both examiners, then the highest and lowest score were removed and the middle score was recorded.

    Time frame: Healing was assessed at 1-week and 2-weeks post surgical intervention.

07

Results

Posted Oct 29, 2026
Limitations and caveats
The healing index relies on visual interpretation and is inherently subjective. Dressing selection in the control group varied between an oxidized cellulose membrane and a collagen dressing depending on provider preference and availability. Graft thickness was not controlled or recorded which may have influenced post-operative morbidity and healing. Multiple mucogingival techniques were included in this trial, introducing additional clinical variability that may have influenced outcomes.

Participant flow

Patients undergoing mucogingival surgery at the United States Air Force postgraduate periodontics program were enrolled. Indications for treatment included patients with \< 2 mm of keratinized tissue (KT), gingival recession, esthetic concerns, peri-implant augmentation, and tissue phenotype conversion. Subjects were screened from March 6, 2024, to February 17, 2025.

Participant flow — Overall Study
MilestoneTest Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose Membrane
Started3939
Completed3939
Not completed00

Outcome measures

PrimaryQuality of Life: Oral Health Impact Profile -14 (OHIP-14). Summative Scores Were Utilized as a Quality of Life Metric at Five Different Time Points. These Scores Were Compared Between the Test and Control Group.

OHIP-14 Questionnaire: includes 7 patient domains (2 questions for each domain). 1. Functional Limitation 2. Physical pain 3. Psychological discomfort 4. Physical disability 5. Psychological disability 6. Social disability 7. Handicap Patients are asked to answer questions on the 5-point Likert scale below. The additive total of the 14 questions is the total OHIP-14 score. Lower scores correlate to higher Quality of Life (QoL). A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted. Likert Scale answer choices: Very Often(4), Fairly Often(3), Occasionally(2), Hardly Ever (1), Never(0). Range: 0-54. High QoL (OHIP Score: \< 19), Moderate QoL (OHIP-14 Score: 19-37), Low QoL (OHIP-14 Score 38-56). OHIP-14 was completed pre-surgically, 24 hours, 72 hours, 1 week, and 2 weeks.

Time frame:
Pre-surgical survey to 2 weeks following surgical intervention.
Reported as:
Median · OHIP-14 Scores
Quality of Life: Oral Health Impact Profile -14 (OHIP-14). Summative Scores Were Utilized as a Quality of Life Metric at Five Different Time Points. These Scores Were Compared Between the Test and Control Group.
OHIP-14 ScoresTest Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose Membrane
Pre-Surgery8 (2 to 16)7 (1 to 15)
24 Hours17 (12 to 24)18 (13 to 27)
72 Hours17 (8 to 23)19 (9 to 27)
1 week13 (8 to 21)18 (10 to 28)
2 weeks8 (4 to 14)12 (6 to 21)
Statistical analysis
  • Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing vs Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane · Mixed Models Analysis · p = 0.181 · Mean difference (net): -2.216 · 95% CI -5.469 to 1.037
PrimarySleep Quality: Sleep Quality Index (SQI) Was Obtained From Wearable Device Which Serves as a Summary Index of the Cardiopulmonary Coupling Biomarkers of Sleep Quality, Sleep Stability, Fragmentation, and Periodicity.

A sleep monitoring device was issued to patients following informed consent (SleepImage® Ring 2019, SleepImage, Denver, CO). The sleep monitoring app will be downloaded on subjects' phones and each subject will be briefed on the function of the application. Subjects will be instructed to wear the device nightly throughout the study. SQI (sleep quality index) scale is 1-100. Higher numbers are consistent with a higher quality sleep. Average baseline (pre-surgery) SQI was recorded. 24 hour, 72 hour, average sleep quality in week 1, and average sleep quality in week 2. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted for sleep analysis.

Time frame:
1 week pre-surgery to 2-weeks following surgical intervention.
Reported as:
Median · Sleep Quality Index (SQI)
Sleep Quality: Sleep Quality Index (SQI) Was Obtained From Wearable Device Which Serves as a Summary Index of the Cardiopulmonary Coupling Biomarkers of Sleep Quality, Sleep Stability, Fragmentation, and Periodicity.
Sleep Quality Index (SQI)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose Membrane
Pre-Surgery SQI45 (34 to 58)46 (30 to 60)
24 hour SQI38 (29 to 65)35 (28 to 53)
72 hour SQI40 (31 to 63)39 (28 to 53)
1 week SQI43 (32 to 55)40 (31 to 58)
2 week SQI46 (34 to 54)42 (31 to 55)
Statistical analysis
  • Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing vs Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane · Mixed Models Analysis · p = 0.452 · Mean difference (net): -0.76 · 95% CI -12.38282 to 5.594516
SecondaryPain: a Numeric Pain Scale (0-10) Was Used to Document Site Specific Palatal Harvest Pain.

The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion asking a question regarding pain at the palatal harvest site. Survey question: What is your pain at the palatal harvest site on a scale of 0-10? (NRS-11). 0 (minimum) indicates no pain. 10 (maximum) is extreme pain. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.

Time frame:
From pre-surgery survey, final survey was 2 weeks post surgical intervention.
Reported as:
Median · Scores on a scale
Pain: a Numeric Pain Scale (0-10) Was Used to Document Site Specific Palatal Harvest Pain.
Scores on a scaleTest Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose Membrane
Pre-Surgical Harvest Site Pain0 (0 to 0)0 (0 to 0)
24-Hour2 (0 to 4)2 (1 to 3)
72 hour2 (1 to 3)2.5 (1 to 4)
1 week2 (0 to 3)3 (1 to 4)
2 week0 (0 to 1)1 (0 to 2)
Statistical analysis
  • Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing vs Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane · Mixed Models Analysis · p = 0.034 · Mean difference (net): -0.717 · 95% CI -1.378 to -0.056
SecondaryAnalgesic Consumption: a (Yes/No) Survey Question Was Asked Regarding Analgesic Consumption. If the Patient Answered "Yes" to Using Medications to Relieve Pain, They Were Added to the Number of Participants Who Used Medication at That Time Point.

The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion. Survey question: Did you take any mediation today to relieve pain or swelling? (yes/no). This was measured by number of participants who took medication to relieve pain and swelling. If a participant answered "Yes" to the survey question at the specific time point, they were counted as having taking medications to relieve pain or swelling. If they answered "No" they were note included. Amount of analgesic use was not documented. Simply a dichotomous "Yes" or "No". A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.

Time frame:
From pre-surgery survey to two weeks post surgical intervention.
Reported as:
Count of participants · Participants
Analgesic Consumption: a (Yes/No) Survey Question Was Asked Regarding Analgesic Consumption. If the Patient Answered "Yes" to Using Medications to Relieve Pain, They Were Added to the Number of Participants Who Used Medication at That Time Point.
ParticipantsTest Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose Membrane
Pre-Surgery2 (0.355 to 0.954)2 (1.734 to 12.358)
24 hours3332
72 hours3030
1 week1928
2 week26
Statistical analysis
  • Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing vs Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane · Mixed Models Analysis · p = 0.032 · Odds ratio (or): 0.58 · 95% CI 0.355 to 0.954
SecondaryPhysiologic Healing at Palatal Donor Site: 5-point Healing Scale Landry et al Scale

At the follow-up appointments the surgeons were asked to document the presence of suppuration or bleeding at the palatal wound site. A standardized photograph was then taken with the following parameters (F-stop: 29, ISO: 200, Shutter Speed: 125). Two calibrated, blinded examiners then assessed the palatal wound based on the Landry et al palatal healing index. Each examiner provided a score (1-5). Lower scores = poorer healing. Higher scores = advanced healing. If the scores were not in concordance, a third calibrated blind examiner assessed the palatal wound based on the Landry et al palatal healing index. This served as the "tie-breaker" score. For example, if examiner #1 scored a (1), and examiner #2 scored a (2), the palate was examined by the third examiner. If examiner #3 scored a (2) then the patient received a score of (2). If the third examiner scored a different number then both examiners, then the highest and lowest score were removed and the middle score was recorded.

Time frame:
Healing was assessed at 1-week and 2-weeks post surgical intervention.
Reported as:
Median · Score on a scale
Physiologic Healing at Palatal Donor Site: 5-point Healing Scale Landry et al Scale
Score on a scaleTest Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose Membrane
1 week3 (2 to 3)2 (2 to 3)
2 week4 (3 to 4)3 (3 to 4)
Statistical analysis
  • Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing vs Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane · Mixed Models Analysis · p = <0.001 · Mean difference (net): 0.474 · 95% CI 0.235 to 0.713
  • Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing vs Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane · Wilcoxon (Mann-Whitney) · p = 0.036 · Median difference (final values): 1
  • Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing vs Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane · Wilcoxon (Mann-Whitney) · p = 0.011 · Median difference (final values): 1

Adverse events

Collected over From enrollment to two weeks post surgical intervention.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing0/39 (0%)0/39 (0%)0/39 (0%)
Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane0/39 (0%)0/39 (0%)0/39 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
Median39 (30 to 59)47 (35 to 64)45 (33 to 61)
Sex: Female, Male
Sex: Female, Male(Participants)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
Female191837
Male202141
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
Count of participants——0
Length of Procedure
Length of Procedure(Minutes)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
Median150 (105 to 180)150 (120 to 180)150 (105 to 180)
Type of Procedure
Type of Procedure(Participants)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
Coronally Advanced Flap (CAF)8614
Free Soft Tissue Autograft (FSTA)151328
Implant + connective tissue graft5712
Implant + FSTA011
Tunneling6612
Vestibular Incision Subperiosteal Tunnel (VISTA)5611
Graft Size
Graft Size(Participants)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
Large Graft Size122032
Medium Graft Size15823
Small Graft Size121123
Type of Sedation
Type of Sedation(Participants)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
IV sedation252651
Local anesthesia alone8614
Nitrous Oxide347
Oral + IV sedation336
Use of intravenous steroids
Use of intravenous steroids(Participants)Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal DressingControl Group: Collagen Wound Dressing or Oxidized Cellulose MembraneTotal
Participants that received IV dexamethasone282957
Participants that did not receive IV dexamethasone111021

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Air Force Post Graduate Dental School
    San Antonio, Texas 78236, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — All de-identified participant date sets are to be shared upon request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Beginning 3 months and ending 3 years after the publication of results.

Access criteria: The Air Force Post Graduate Dental School will be in charge of allowing access to IPD upon request.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in Mar 2025, 9 months.

Results were first posted in Oct 2026, 1 year 7 months after primary completion.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 9 months is below that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2026
First posted
Jun 10, 2026
StartActual
May 24, 2024
Primary completionActual
Mar 18, 2025
CompletionActual
Mar 18, 2025
Results first posted
Oct 29, 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 29, 2026
Interventions
Arms added: Test Group: Horizontally Centrifuged PRF membranes used as palatal dressing·Control Group: Collagen wound dressing or oxidized cellulose membrane; arms removed: Quality of Life·Sleep Quality·Healing
Oct 29, 2026
Primary outcomes
2 edited
What changed in the outcomes
  • EditedQuality of Life: Oral Health Impact Profile -14 (OHIP-14 summative scores utilized). Summative Scores Were Utilized as a qualityQuality of life metricLife Metric at five different time pointsFive Different Time Points. These scores were compared betweenScores Were Compared Between the testTest and control groupControl Group.Time frame: Pre-surgical survey to 2 weeks following surgical intervention.
  • ChangedBefore Sleep Quality: sleep efficiency index obtained from wearable device.Now Sleep Quality: Sleep Quality Index (SQI) Was Obtained From Wearable Device Which Serves as a Summary Index of the Cardiopulmonary Coupling Biomarkers of Sleep Quality, Sleep Stability, Fragmentation, and Periodicity.Time frame: 1 week pre-surgery to 2-weeks following surgical intervention.
Oct 29, 2026
Secondary outcomes
3 edited
What changed in the outcomes
  • EditedPain: a numeric pain scaleNumeric Pain Scale (0-10) was usedWas Used to document site specific palatal harvest painDocument Site Specific Palatal Harvest Pain.Time frame: From pre-surgery survey, final survey was 2 weeks post surgical intervention.
  • EditedPhysiologic Healing at Palatal Donor Site: 5-point healing scaleHealing Scale Landry et al ScaleTime frame: Healing was assessed at 1-week and 2-weeks post surgical intervention.
  • ChangedBefore Analgesic Consumption: a survey tool was used to document patients medication use post-surgery.Now Analgesic Consumption: a (Yes/No) Survey Question Was Asked Regarding Analgesic Consumption. If the Patient Answered "Yes" to Using Medications to Relieve Pain, They Were Added to the Number of Participants Who Used Medication at That Time Point.Time frame: From pre-surgery survey to two weeks post surgical intervention.
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Results posted
    Primary outcomes 2 edited
    What changed in the outcomes
    • EditedQuality of Life: Oral Health Impact Profile -14 (OHIP-14 summative scores utilized). Summative Scores Were Utilized as a qualityQuality of life metricLife Metric at five different time pointsFive Different Time Points. These scores were compared betweenScores Were Compared Between the testTest and control groupControl Group.Time frame: Pre-surgical survey to 2 weeks following surgical intervention.
    • ChangedBefore Sleep Quality: sleep efficiency index obtained from wearable device.Now Sleep Quality: Sleep Quality Index (SQI) Was Obtained From Wearable Device Which Serves as a Summary Index of the Cardiopulmonary Coupling Biomarkers of Sleep Quality, Sleep Stability, Fragmentation, and Periodicity.Time frame: 1 week pre-surgery to 2-weeks following surgical intervention.
    Secondary outcomes 3 edited
    What changed in the outcomes
    • EditedPain: a numeric pain scaleNumeric Pain Scale (0-10) was usedWas Used to document site specific palatal harvest painDocument Site Specific Palatal Harvest Pain.Time frame: From pre-surgery survey, final survey was 2 weeks post surgical intervention.
    • EditedPhysiologic Healing at Palatal Donor Site: 5-point healing scaleHealing Scale Landry et al ScaleTime frame: Healing was assessed at 1-week and 2-weeks post surgical intervention.
    • ChangedBefore Analgesic Consumption: a survey tool was used to document patients medication use post-surgery.Now Analgesic Consumption: a (Yes/No) Survey Question Was Asked Regarding Analgesic Consumption. If the Patient Answered "Yes" to Using Medications to Relieve Pain, They Were Added to the Number of Participants Who Used Medication at That Time Point.Time frame: From pre-surgery survey to two weeks post surgical intervention.
    Interventions Arms added: Test Group: Horizontally Centrifuged PRF membranes used as palatal dressing·Control Group: Collagen wound dressing or oxidized cellulose membrane; arms removed: Quality of Life·Sleep Quality·Healing
    + 3 other changes: registry notes, index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07637838
Lead sponsor
59th Medical Wing
Responsible party
David Seiler (Periodontics Resident, Air Force Officer, 59th Medical Wing) — Principal investigator
First posted
Jun 10, 2026
Start date
May 24, 2024
Primary completion
Mar 18, 2025
Completion
Mar 18, 2025
Results posted
Oct 29, 2026
Last update
Oct 29, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion